Two prospective randomized controlled trials have confirmed that a new standard (BNP≥50 pg/mL or NT-proBNP>125 pg/ml) can screen high-risk DM populations properly to reduce the incidence of cardiovascular hospitalizations/death or heart failure (173, 174). Here, NPPB is linked to diabetes mellitus.